Wei Wei,Huaxun Wu,Fang Gu,Jun Xu,Hongwei Xie,Guang Xu,Jie Fu,Xuezheng Wang
申请号：
US16740570
公开号：
US20200147116A1
申请日:
2020.01.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention discloses the use of paeoniflorin-6′；-O-benzenesulfonate of formula I in treatment of Sjögren's syndrome. Paeoniflorin-6′；-O-benzenesulfonate of the invention, which has definitely curative effect, is characterized superiorly in that, it could be taken clinically for a long time with small dosage, mild adverse reaction and good patient compliance. The molecular formula of paeoniflorin-6′；-O-benzenesulfonate is C29H32O13S, and the chemical structure is shown in Formula I.
